Meet Astherna at Bio-Europe 2025
30 October 2025
The Astherna team will be attending BIO-EUROPE® 2025 in Vienna from November 3–5! We are…
Join Prof. Rob Collin at OTS 2025 — retinal ASO therapies
17 October 2025
Our CEO and co-founder, Prof. Rob Collin, will be taking the stage at the Oligonucleotide Therapeutics Society…
Alice Randon begins PhD on AMD therapies at Astherna!
20 August 2025
Alice joined us as a PhD candidate through the prestigious Marie Skłodowska-Curie Actions (MSCA) Doctoral Network…
Dr. Kaltak presents USH2A exon skipping strategy at USH2025
18 June 2025
On Friday, June 20, our Chief Scientific Officer, Dr. Melita Kaltak, will be speaking at…
Dr. Erwin van Wijk shares Usher research insights at Kalorama
4 June 2025
Tomorrow, our Head of Preclinical Development, Dr. Erwin van Wijk, will visit Kalorama, a care…
See you at the USH2025 Symposium in Nijmegen!
29 May 2025
We are looking forward to the USH2025 Symposium that is taking place from June 19–21…